Doctors Tried To Lower $148K Cancer Drug Cost; Makers Tripled Its Price

https://science.slashdot.org/story/18/04/21/1813233/doctors-tried-to-lower-148k-cancer-drug-cost-makers-tripled-its-price

        Imbruvica, a compound that treats white blood cell cancers,
        has until now been a bargain at $148,000 per year. Until now,
        doctors have been able to optimize dosage for each patient by
        prescribing up to four small-dose pills of it per day.  But
        after results from a recent small pilot trial indicated that
        smaller doses would for most patients work as well as the
        large ones, its manufacturer, Janssen and Pharmacyclics, has
        decided on the basis of the doctors' interest in smaller
        dosages to reprice all sizes of the drug to the price of the
        largest size. This has the effect of tripling the price for
        patients, and doctors have now put off any plans for further
        testing of lower dosages.

 - - -

These big pharma execs should be in prison. They kill more people
collectively than all the felons in all the prisons in the USA.

--Lauren--
Lauren Weinstein ([email protected]): https://www.vortex.com/lauren 
Lauren's Blog: https://lauren.vortex.com
Google Issues Mailing List: https://vortex.com/google-issues
Founder: Network Neutrality Squad: https://www.nnsquad.org 
         PRIVACY Forum: https://www.vortex.com/privacy-info
Co-Founder: People For Internet Responsibility: https://www.pfir.org/pfir-info
Member: ACM Committee on Computers and Public Policy
Google+: https://google.com/+LaurenWeinstein
Twitter: https://twitter.com/laurenweinstein
Tel: +1 (818) 225-2800
_______________________________________________
pfir mailing list
https://lists.pfir.org/mailman/listinfo/pfir

Reply via email to